200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 124351-86-6

124351-86-6

124351-86-6 | Phosphonic acid, P,P'-[(cyclooctylamino)methylene]bis-

CAS No: 124351-86-6 Catalog No: AG000LXF MDL No:

Product Description

Catalog Number:
AG000LXF
Chemical Name:
Phosphonic acid, P,P'-[(cyclooctylamino)methylene]bis-
CAS Number:
124351-86-6
Molecular Formula:
C9H21NO6P2
Molecular Weight:
301.2137
IUPAC Name:
[(cyclooctylamino)-phosphonomethyl]phosphonic acid
InChI:
InChI=1S/C9H21NO6P2/c11-17(12,13)9(18(14,15)16)10-8-6-4-2-1-3-5-7-8/h8-10H,1-7H2,(H2,11,12,13)(H2,14,15,16)
InChI Key:
YLTFIVZSTCIQHV-UHFFFAOYSA-N
SMILES:
OP(=O)(C(P(=O)(O)O)NC1CCCCCCC1)O
NSC Number:
723988

Properties

Complexity:
321  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
301.084g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
301.216g/mol
Monoisotopic Mass:
301.084g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
127A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3  

Literature

Title Journal
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin. Journal of medicinal chemistry 20061214
Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. Journal of medicinal chemistry 20050505
Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. Journal of medicinal chemistry 20040115
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo. Journal of medicinal chemistry 20040101
3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates. Journal of medicinal chemistry 20031120

Related Products

© 2019 Angene International Limited. All rights Reserved.